Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...
Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...
BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced preliminary data from ongoing Phase 1 clinical studies of its antibody-drug conjugate micvotabart pelidotin (MICVO) in patients with ...
LONDON, Nov. 18, 2025 /PRNewswire/ -- Compass Box Scotch Whiskymakers announce the launch of Pyxis, a first-of-its-kind AI-powered whisky guide designed to make exploration more personal, effortless, ...
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that ...
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in ...
At NAB 2025 in Las Vegas, Blackmagic Design announced the PYXIS 12K, a full-frame digital cinema camera with a 12K RGBW sensor, modular build, and cloud-based workflow tools. It’s priced at $4,995 and ...
Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! Blackmagic PYXIS 12K ...
Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! NAB 2025 -Blackmagic ...
Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its workforce by "approximately" 20%, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results